Log in to your Inderes Free account to see all free content on this page.
Vivesto
0.08 SEK
+4.34 %
Less than 1K followers
VIVE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vivesto
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 2.0 | 201.8 | 26.2 | 1.0 | |||
| growth-% | 10,094.1 % | -87.0 % | -96.1 % | ||||
| EBITDA | -113.5 | -10.1 | -99.8 | -90.5 | -74.8 | -27.4 | -32.6 |
| EBIT | -120.1 | -30.7 | -128.6 | -165.0 | -132.2 | -42.0 | -34.4 |
| Profit before taxes | -138.2 | -43.9 | -132.7 | -166.7 | -128.7 | -39.8 | -34.1 |
| Net income | -171.0 | -11.1 | -132.7 | -166.7 | -128.7 | -39.8 | -34.1 |
| EPS | -0.55 | -0.02 | -0.26 | -0.30 | -0.21 | -0.06 | -0.05 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | -5,734.6 % | -5.0 % | -380.9 % | -8,875.5 % | |||
| EBIT-% | -6,067.3 % | -15.2 % | -491.2 % | -16,177.5 % | |||
| ROE | -40.3 % | -1.3 % | -24.1 % | -32.3 % | -65.1 % | -25.1 % | -27.4 % |
| ROI | -26.5 % | -1.1 % | -22.3 % | -30.5 % | -58.3 % | -23.0 % | -22.9 % |
Login required
This content is only available for logged in users